1153例寒湿痹阻证类风湿关节炎患者真实世界用药规律研究OA
A Real-World Study on Medication Patterns in 1,153 Patients with Rheumatoid Arthritis of Cold-Dampness Obstruction Syndrome
目的 基于数据挖掘分析中医药治疗寒湿痹阻证类风湿关节炎(rheumatoid arthritis,RA)的用药规律,为临床提供参考.方法 回顾性分析 2019 年 1 月至2022 年12 月"问问风湿患者平台"RA患者的就诊资料,采用统计学方法对中药进行频率、关联规则、系统聚类分析.结果 研究共纳入 1153 份就诊资料,临床疾病活动指数(CDAI)改善明显者共 437 例,占比 37.90%,常用方剂为桂枝芍药知母汤、乌头汤等;高频用药为白芍、甘草、麻黄等 27 味;常用药物组合为白芍-甘草、白芍-桂枝等;系统聚类分析形成 4 类药物组合,其中Ⅱ类药物(白芍、甘草、桂枝、知母、防风等)可能是治疗RA寒湿痹阻证的核心药方.长病程组多以活血祛风、补益肝肾为主,短病程组多以发散解表、健脾化湿为主.主要症状(怕风怕冷)改善率达 32.87%,兼症(疲乏、失眠、胃口不佳)改善率分别为 28.45%、30.27%、27.32%.剔除《类风湿关节炎病证结合诊疗指南》推荐方剂所含中药后,发现姜黄、续断能改善疲乏;羌活、熟地黄能改善失眠;骨碎补、熟地黄能改善胃口不佳.结论 真实世界中应用中医药治疗RA寒湿痹阻证具有一定疗效及用药规律,其中Ⅱ类药方可能是降低患者CDAI的核心药方,部分中药在改善主症的同时,对常见兼症亦有明显改善作用.
Objective To analyze the medication patterns of traditional Chinese medicine(TCM)in treating rheumatoid arthritis(RA)of cold-dampness obstruction syndrome(Hanshi Bizu Zheng)based on data mining,providing clinical reference.Methods A retrospective analysis was conducted on clinical data of RA patients from the"Ask Rheumatism Patient Platform"between January 2019 and December 2022.Statistical methods,including frequency analysis,association rule analysis,and hierarchical clustering analysis,were applied to the TCM prescriptions.Results The study included 1,153 clinical records.Among them,437 cases(37.90%)showed significant improvement in the Clinical Disease Activity Index(CDAI).Commonly used formulas included Guizhi Shaoyao Zhimu Tang and Wutou Tang.High-frequency herbs included Baishao(Paeoniae Radix Alba),Gancao(Glycyrrhizae Radix Et Rhizoma),and Mahuang(Ephedrae Herba),totaling 27 herbs.Common herb combinations in the treatment included Baishao-Gancao and Baishao-Guizhi.Through hierarchical clustering analysis,four distinct herb clusters were identified.Among these,Cluster Ⅱ—comprising herbs such as Baishao,Gancao,Guizhi(Cinnamomi Ramulus),Zhimu(Anemarrhenae Rhizoma),and Fangfeng(Saposhnikoviae Radix)—may serve as the core prescription for managing RA characterized by cold-dampness obstruction syndrome.In the long-disease-duration group,herbs for activating blood,dispelling wind,tonifying the liver and kidney were predominant,while in the short-disease-duration group,herbs for dispersing pathogens,relieving the exterior,strengthening the spleen,and resolving dampness were more common.The improvement rate for the main symptom(aversion to wind and cold)was 32.87%,while improvement rates for accompanying symptoms(fatigue,insomnia,poor appetite)were 28.45%,30.27%,and 27.32%,respectively.After excluding herbs recommended in the Guidelines for Combined Disease and Syndrome Diagnosis and Treatment of Rheumatoid Arthritis,it was found that Jianghuang(Curcumae Longae Rhizoma)and Xuduan(Dipsaci Radix)improved fatigue;Qianghuo(Notopterygii Rhizoma Et Radix)and Shudihuang(Rehmanniae Radix Praeparata)improved insomnia;and Gusuibu(Drynariae Rhizoma)and Shudihuang improved poor appetite.Conclusion In real-world clinical practice,TCM demonstrates certain efficacy and identifiable medication patterns in treating RA of cold-dampness obstruction syndrome.Cluster Ⅱ may represent the core prescription for reducing CDAI in patients.Some herbs not only alleviate main symptoms but also significantly improve common accompanying symptoms.
申钲瑶;杨煜辰;姜泉;马协丽;刘子夏;常甜;巩勋
中国中医科学院广安门医院,北京 100053中国中医科学院广安门医院,北京 100053中国中医科学院广安门医院,北京 100053中国中医科学院广安门医院,北京 100053中国中医科学院广安门医院,北京 100053中国中医科学院广安门医院,北京 100053中国中医科学院广安门医院,北京 100053
医药卫生
类风湿关节炎寒湿痹阻证用药规律CDAI真实世界
Rheumatoid arthritisCold-dampness obstruction syndromeMedication patternsCDAIReal-world study
《中国中医基础医学杂志》 2026 (2)
401-406,6
国家自然科学基金项目(82274507)中央高水平中医医院临床科研业务费项目(HLCMHPP2023087)
评论